¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
9/4ÀÏ ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
ÀÛ¼ºÀÏ
2021-09-03
Á¶È¸¼ö
231


¾È³çÇϼ¼¿ä. À̹øÁÖ Åä¿äÀÏ ¼¼¹Ì³ª ¹ßÇ¥ÀÚ ÀÌÁ¤Ã¶ ÀÔ´Ï´Ù.


Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº 2020³â 11¿ù¿¡ cell reports¿¡ Ãâ°£µÈ 'A Two-Step Process of Effector Programming Governs CD4+ T Cell Fate Determination Induced by Antigenic Activation in the Steady State'ÀÔ´Ï´Ù.

ÀáÀçÀûÀÎ ÀÚ°¡¸é¿ª±â´ÉÀ» °¡Áø effector T cellÀÇ Çü¼ºÀ» Áö¹èÇÏ°í ÀÖ´Â steady state¿¡¼­ÀÇ ¸ÞÄ¿´ÏÁòÀº ¾ÆÁ÷±îÁö ¸íÈ®ÇÏ°Ô ¹àÇôÁø ¹Ù°¡ ¾ÆÁ÷ ¾ø½À´Ï´Ù.

ÇØ´ç ¿¬±¸ÆÀÀº effectur precursorÀÇ À¯µµ°¡ Hopx ¹ßÇö°ú ¸»´Ü È¿°ú±â ºÐÈ­·Î °¢ÀÎµÈ µÎ°¡Áö stepÀ¸·Î ½ÃÀÛÇÑ´Ù´Â °ÍÀ» ¹àÇô³»¾ú½À´Ï´Ù.

cDC¿Í effector T cell ¹× immune tolerance¿¡ ´ëÇÑ ÀÌÇظ¦ ³ôÀ̱â À§ÇØ ÇØ´ç ³í¹®À» ¼±Á¤ÇÏ¿© °øºÎÇÏ°Ô µÇ¾ú½À´Ï´Ù.


¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.


°¨»çÇÕ´Ï´Ù.

³í¹® ¸µÅ©: https://www.sciencedirect.com/science/article/pii/S2211124720314133?via%3Dihub
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
9/11 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº¿ÃÇØ JCI(The Journal of Clinical Investigation)¿¡ ÃâÆÇ µÈ "UDP-glucose and P2Y14 receptor amplify allergen-induced airway eosinophilia " ÀÔ´Ï´Ù. ÀÌ ³í¹®¿¡¼­´Â UDP-glucose(UDP-G)°¡ allergen challenge ÈÄ Áõ°¡ÇÏ´Â °ÍÀ» È®ÀÎÇÏ¿´À¸..
ÀÌÀü±Û
9/4ÀÏ ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
±³¼ö´Ô²² À̹øÁÖ Åä¿ä ¼¼¹Ì³ª ¹ßÇ¥ ³í¹® º¸³»µå¸³´Ï´Ù. Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº Cell host & microbe¿¡ ÃâÆÇµÈ 'Enhancement of IFNγ Production by Distinct Commensals Ameliorates Salmonella-Induced Disease' ÀÔ´Ï´Ù. Probiotics¸¦ vaccine°ú ÁÙ ½Ã Àå³»¹Ì³¾¹° ±ÕÃÑÀ» ÀÌ·Ó°Ô ÇÏ°í ¶ÇÇÑ..